Literature DB >> 12889602

Proteomic characterization of nipple aspirate fluid: identification of potential biomarkers of breast cancer.

Susan M Varnum1, Chandice C Covington, Ronald L Woodbury, Konstantinos Petritis, Lars J Kangas, Mohamed S Abdullah, Joel G Pounds, Richard D Smith, Richard C Zangar.   

Abstract

Mammary ductal cells are the origin for 70-80% of breast cancers. Nipple aspirate fluid (NAF) contains proteins directly secreted by the ductal and lobular epithelium in non-lactating women. Proteomic approaches offer a largely unbiased way to evaluate NAF as a source of biomarkers and are sufficiently sensitive for analysis of small NAF volumes (10-50 microl). In this study, we initially evaluated a new process for obtaining NAF and discovered that this process resulted in a volume of NAF that was suitable for analysis in approximately 90% of subjects. Proteomic characterization of NAF identified 64 proteins. Although this list primarily includes abundant and moderately abundant NAF proteins, very few of these proteins have previously been reported in NAF. At least 15 of the NAF proteins identified have previously been reported to be altered in serum or tumor tissue from women with breast cancer, including cathepsin D and osteopontin. In summary, this study provides the first characterization of the NAF proteome and identifies several candidate proteins for future studies on breast cancer markers in NAF.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12889602     DOI: 10.1023/A:1024479106887

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  25 in total

1.  Improved peptide elution time prediction for reversed-phase liquid chromatography-MS by incorporating peptide sequence information.

Authors:  Konstantinos Petritis; Lars J Kangas; Bo Yan; Matthew E Monroe; Eric F Strittmatter; Wei-Jun Qian; Joshua N Adkins; Ronald J Moore; Ying Xu; Mary S Lipton; David G Camp; Richard D Smith
Journal:  Anal Chem       Date:  2006-07-15       Impact factor: 6.986

Review 2.  Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications.

Authors:  Wei-Jun Qian; Jon M Jacobs; Tao Liu; David G Camp; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2006-08-03       Impact factor: 5.911

3.  Macrophage responses to silica nanoparticles are highly conserved across particle sizes.

Authors:  Katrina M Waters; Lisa M Masiello; Richard C Zangar; Barbara J Tarasevich; Norman J Karin; Ryan D Quesenberry; Somnath Bandyopadhyay; Justin G Teeguarden; Joel G Pounds; Brian D Thrall
Journal:  Toxicol Sci       Date:  2008-12-10       Impact factor: 4.849

Review 4.  Status and prospects for discovery and verification of new biomarkers of cardiovascular disease by proteomics.

Authors:  Robert E Gerszten; Aarti Asnani; Steven A Carr
Journal:  Circ Res       Date:  2011-08-05       Impact factor: 17.367

5.  Towards preventive medicine. High-throughput methods from molecular biology are about to change daily clinical practice.

Authors:  Hrvojka Bosnjak; Kresimir Pavelic; Sandra Kraljevic Pavelic
Journal:  EMBO Rep       Date:  2008-10-10       Impact factor: 8.807

6.  High dynamic range characterization of the trauma patient plasma proteome.

Authors:  Tao Liu; Wei-Jun Qian; Marina A Gritsenko; Wenzhong Xiao; Lyle L Moldawer; Amit Kaushal; Matthew E Monroe; Susan M Varnum; Ronald J Moore; Samuel O Purvine; Ronald V Maier; Ronald W Davis; Ronald G Tompkins; David G Camp; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2006-05-09       Impact factor: 5.911

7.  Electrochemical immunoassay for lactalbumin based on the use of ferrocene-modified gold nanoparticles and lysozyme-modified magnetic beads.

Authors:  Abdelmoneim Mars; Sinda Ben Jaafar; Amel Ben Ammar-El Gaied; Noureddine Raouafi
Journal:  Mikrochim Acta       Date:  2018-09-07       Impact factor: 5.833

8.  Metabolomic characterization of nipple aspirate fluid by (1)H NMR spectroscopy and GC-MS.

Authors:  Gregory D Tredwell; Jessica A Miller; H-H Sherry Chow; Patricia A Thompson; Hector C Keun
Journal:  J Proteome Res       Date:  2014-01-07       Impact factor: 4.466

9.  Protein modifications as potential biomarkers in breast cancer.

Authors:  Hongjun Jin; Richard C Zangar
Journal:  Biomark Insights       Date:  2009-11-30

10.  A Comparison of the Proteomic Expression in Pooled Saliva Specimens from Individuals Diagnosed with Ductal Carcinoma of the Breast with and without Lymph Node Involvement.

Authors:  Charles F Streckfus; Karen A Storthz; Lenora Bigler; William P Dubinsky
Journal:  J Oncol       Date:  2009-12-20       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.